Market Place
Sourcing Support
All News #Library
Biotech
Seismic Therapeutics Updates Time at 44th J.P. Morgan Conference
06 Jan 2026 //
GLOBENEWSWIRE
Seismic Doses First Cohort in Phase 1 Clinical Trial of S-4321
10 Apr 2025 //
BUSINESSWIRE
S?1117 Phase 1 Trial: Seismic Doses for Antibody Diseases
11 Mar 2025 //
BUSINESSWIRE
Seismic Presents S-1117 Data for Immune Thrombocytopenia at ASH
09 Dec 2024 //
BUSINESSWIRE
Seismic Presents Preclinical Data on S-4321 for Autoimmune Diseases
18 Nov 2024 //
BUSINESSWIRE
Seismic Therapeutics to Present at Upcoming Scientific Conferences
05 Nov 2024 //
BUSINESSWIRE
Seismic Presents Data On S-1117 In Autoantibody Diseases
15 Oct 2024 //
BUSINESSWIRE
Seismic Therapeutic Appoints Julie Eastland To Board
23 Sep 2024 //
BUSINESSWIRE
Seismic: S-1117 Autoimmune Preclinical Data At AAN 2024
12 Apr 2024 //
BUSINESSWIRE
Seismic to Present Preclinical Data for Novel Immunoglobulin Sculpting Enzyme
08 Mar 2024 //
BUSINESSWIRE
Seismic Announces Presentation of Data for Advancing Biologics Drug Programs
14 Jun 2023 //
BUSINESSWIRE
Seismic Announces Presentation of Data Showing Advances in Biologics Discovery
11 May 2023 //
BUSINESSWIRE
Seismic Announces Preclinical Data for Immunoglobin Sculpting Enzyme
09 May 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.